Literature DB >> 3436617

Evidence for decreased tubular reabsorption of calcium in glucocorticoid-treated asthmatics.

I R Reid1, H K Ibbertson.   

Abstract

Fasting urine calcium excretion was measured in 15 asthmatic patients receiving long-term glucocorticoid therapy (steroid group) and in age- and sex-matched asthmatics not receiving these drugs. In the steroid group, the mean urinary calcium/creatinine ratio and the mean calcium excretion per liter of glomerular filtrate (CaE) were both approximately twice the control values (p less than 0.005). When CaE was plotted as a function of serum calcium it more often exceeded the mean normal value in the steroid-treated patients than in the controls (p less than 0.05), suggesting a reduction in tubular calcium reabsorption. Calculation of the tubular maximum for calcium reabsorption confirmed a significant reduction in the glucocorticoid-treated patients (p less than 0.005). It is concluded that glucocorticoid drugs probably inhibit the tubular reabsorption of calcium and that this is likely to contribute to the development of osteoporosis in patients receiving this treatment.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3436617     DOI: 10.1159/000180820

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  16 in total

Review 1.  The epithelial calcium channels TRPV5 and TRPV6: regulation and implications for disease.

Authors:  Monique van Abel; Joost G J Hoenderop; René J M Bindels
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

2.  Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients.

Authors:  L Montemurro; G Schiraldi; P Fraioli; G Tosi; A Riboldi; G Rizzato
Journal:  Calcif Tissue Int       Date:  1991-08       Impact factor: 4.333

Review 3.  Steroid osteoporosis.

Authors:  I R Reid
Journal:  Calcif Tissue Int       Date:  1989-08       Impact factor: 4.333

Review 4.  The effects of smoking on bone metabolism.

Authors:  V Yoon; N M Maalouf; K Sakhaee
Journal:  Osteoporos Int       Date:  2012-02-21       Impact factor: 4.507

5.  Bone loss after liver transplantation is not prevented by cyclical etidronate, calcium and alphacalcidol. The Liver Transplant Group, Groningen.

Authors:  S C Riemens; A Oostdijk; J J van Doormaal; C J Thijn; G Drent; D A Piers; E W Groen; L Meerman; M J Slooff; E B Haagsma
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

6.  Synergistic antiosteoporotic effect of Lepidium sativum and alendronate in glucocorticoid-induced osteoporosis in Wistar rats.

Authors:  Mohamed F Elshal; Abdulrahman L Almalki; Hussein K Hussein; Jalal A Khan
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-08-12

7.  Change in bone mineral density at one year following glucocorticoid withdrawal in kidney transplant recipients.

Authors:  Steven W Ing; Loraine T Sinnott; Sirisha Donepudi; Elizabeth A Davies; Ronald P Pelletier; Nancy E Lane
Journal:  Clin Transplant       Date:  2010-10-21       Impact factor: 2.863

8.  The assessment of the systemic effects of inhaled glucocorticosteroids. The effects of inhaled budesonide vs oral prednisolone on calcium metabolism.

Authors:  B H Jennings; K E Andersson; S A Johansson
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 9.  Skeletal involvement in adult patients with endogenous hypercortisolism.

Authors:  I Chiodini; M Torlontano; V Carnevale; V Trischitta; A Scillitani
Journal:  J Endocrinol Invest       Date:  2008-03       Impact factor: 4.256

10.  Loss of bone mineral density in premenopausal women with systemic lupus erythematosus.

Authors:  F Formiga; I Moga; J M Nolla; M Pac; F Mitjavila; D Roig-Escofet
Journal:  Ann Rheum Dis       Date:  1995-04       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.